DME

Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Regeneron
Genentech
diabetes
Eylea
Lucentis
DME
diabetic macular edema
Roche's blockbuster Lucentis nabs fourth FDA approval
BioPharma Dive
Mon, 02/9/15 - 06:01 pm
Roche
Lucentis
FDA
DME
diabetic macular edema
Iluvien And Tethadur: Sustained Release Treatments With Big Potential For pSivida
Seeking Alpha
Fri, 08/16/13 - 09:13 am
Iluvien
Tethadur
pSivida
Alimera
posterior uveitis
DME
Regeneron Posts Rare Sales Miss But Counters With Early FDA Filing
TheStreet.com
Tue, 08/6/13 - 11:00 am
Regeneron
FDA
earnings
Eylea
DME
Ampio's Eye Drug Approval Strategy Dealt Another Credibility Hit
TheStreet.com
Tue, 08/6/13 - 10:54 am
Ampio Pharmaceuticals
Regeneron
Eylea
Optina
DME
Alimera Sciences announces first patient treated with Iluvien
Yahoo/Fly on the Wall
Wed, 05/8/13 - 09:10 am
Alimera
Iluvien
DME
diabetic macular edema
For Iluvien, The FDA Isn't The Issue; European Sales Are
Seeking Alpha
Wed, 04/24/13 - 09:37 am
FDA
Iluvien
DME
diabetic macular edema
pSivida
Alimera
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Yahoo
Wed, 02/20/13 - 05:12 pm
Bayer
Eyelea
Regeneron
Russia
Asia
DME
diabetic macular edema
1 Pharma Receiving Nice News (NVS)
Motley Fool
Wed, 10/10/12 - 11:16 am
NICE
Novartis
Lucentis
DME
diabetic macular edema